Female Contraceptive Market Share

Statistics for the 2023 & 2024 Female Contraceptive market share, created by Mordor Intelligence™ Industry Reports. Female Contraceptive share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Female Contraceptive Industry

The female contraceptive market is fragmented and competitive. As the concern of unwanted pregnancy is rising in various countries across the globe, there is a great opportunity for companies to grab a significant market share. The companies are focusing on entering the market with cost-effective drugs or devices and these companies may pose a strong competition to the current market players. Some of the major players in the market are Bayer AG, Pfizer Inc, Merck & Co, Inc., Teva Pharmaceuticals, Agile Therapeutics, Johnson and Johnson, and Fuji Latex Co. Ltd.

Female Contraceptive Market Leaders

  1. Bayer AG

  2. Pfizer Inc

  3. Teva Pharmaceuticals

  4. Agile Therapeutics

  5. Organon

*Disclaimer: Major Players sorted in no particular order

Female Contraceptive Market Concentration

Female Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)